Drug profile · INN
diatrizoate sodium
MD-50
diatrizoate sodium (MD-50) is a diagnostic agent. Route of administration: oral, rectal. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — diatrizoate sodium
- US status
- approved
- Class
- —
- Route
- ORAL, RECTAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
diatrizoate sodium (MD-50) is a diagnostic agent. Route of administration: oral, rectal. Current US regulatory status: approved.
Key facts
INN diatrizoate sodium
Brand MD-50
Mechanism Diagnostic agent
Route ORAL, RECTAL
Formulation INJECTABLE
Mechanism of action
Diagnostic agent
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is diatrizoate sodium?
diatrizoate sodium (MD-50) is a diagnostic agent. Route of administration: oral, rectal. Current US regulatory status: approved.
What is the brand name for diatrizoate sodium?
MD-50 is a marketed brand name for diatrizoate sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of diatrizoate sodium?
diatrizoate sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.